DP
Diagnosis and Prognosis

Thursday, June 2, 2016: 6:15 PM-8:15 PM
Exhibit Hall
DP01
Balo's Concentric Sclerosis:10 Years Follow-up
Anna Kazimirchik, RN MSCN, Fraser Health Multiple Sclerosis Clinic

DP02
A Case of Severe Multiple Sclerosis Reactivation Following Fingolimod Cessation
Erika Mitchell, FNP-C, MedStar Georgetown University Hospital; Faria Amjad, MD, MedStar Georgetown University Hospital
PDF
DP03
Paroxysmal Dystonia in Inflammatory Disorders of the Central Nervous System. a Southeastern Michigan Cohort Study
Helena Bulka, DO, Henry Ford Hospital; Suzanne Croll, BSc, Henry Ford Hospital; Stanton Elias, MD, Henry Ford Hospital; Mirela Cerghet, MD, PhD, Henry Ford Hospital
PDF
DP04
Pigmented Purpuric Dermatoses (PPD) Associated with Radiologically Isolated Syndrome (RIS): Is There a Relationship?
Jay H Rosenberg, MD, Staff Physician MS Center of Southern CA; Michael Zorniak, Ph.D., MSL at Teva Pharmaceuticals
PDF
DP05
Stiff Person Syndrome Masquerading As Multiple Sclerosis
Joseph J Sabatino Jr., MD/PhD, Johns Hopkins Hospital; Scott D Newsome, D.O., Johns Hopkins School of Medicine; Scott D Newsome, D.O., Johns Hopkins School of Medicine
PDF
DP06
PML and IRIS: Between a Rock and a Hard Place
Joshua D Katz, M.D., The Elliot Lewis Center for Multiple Sclerosis Care; Ellen S Lathi, M.D., The Elliot Lewis Center for Multiple Sclerosis Care; Lauren M Heyda, B.S., The Elliot Lewis Center for Multiple Sclerosis Care; David Titelbaum, M.D., Shields MRI

DP07
Use of Optical Coherence Tomography As a Diagnostic Tool for Suspected Multiple Sclerosis in a Tertiary Center
Kathryn B Holroyd, BA, Johns Hopkins; Kathryn Fitzgerald, ScD, Johns Hopkins Hospital; Scott D Newsome, D.O., Johns Hopkins School of Medicine; Shiv Saidha, MD, Johns Hopkins University; Peter A Calabresi, MD, Johns Hopkins University; Ellen Mowry, MD, MCR, Johns Hopkins School of Medicine; Kathryn B Holroyd, BA, Johns Hopkins
PDF
DP08
Azathioprine-Induced Life-Threatening Myelotoxicity in a Patient with Multiple Sclerosis: Are We Utilizing TPMT Activity Testing to Identify Susceptible Individuals?
Weredeselam M Olango, MD, Rutgers NJMS; Larysa Gromko, MD, Rutgers NJMS; Michael Jaker, MD, Rutgers NJMS; Machteld Hillen, MD, Rutgers NJMS

DP09
Paroxysmal Kinesogenic Dyskinesia As a Presenting Symptom of Neuromyelitis Optica
Weredeselam M Olango, MD, Rutgers NJMS; Machteld Hillen, MD, Rutgers NJMS

See more of: CMSC
<< Previous Session | Next Session >>